Commission Implementing Decision (EU) 2018/1305 of 26 September 2018 on the terms and conditions of the authorisation of a biocidal product family containing deltamethrin referred by Sweden in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document number C(2018) 5503) (Text with EEA relevance.)

• CELEX: Implementing Decision (EU) 2018/1305
• Articles: 3

Article 1

This Decision applies to the biocidal product family identified by the asset number SE-0017809-0000 in the Register for Biocidal Products.

Article 2

The minimum and maximum percentage for the concentration of the active substance in the biocidal product family referred to in Article 1, as referred to in Article 22(2)(e) of Regulation (EU) No 528/2012, shall be expressed by considering the active substance as it was approved, which includes the main constituent of the active substance and any additives or impurities.

Under the terms and conditions set out in paragraph 1, the biocidal product family referred to in Article 1 meets the conditions laid down in Article 19(1)(c) of Regulation (EU) No 528/2012.

Article 3

This Decision is addressed to the Member States.